KATHRYN GUILBEAU: Open Payments
NPI 1821725219 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 61 payments from 20 companies in 2025. Trend: 2023 $1,139 · 2024 $777 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 8 | $158 |
| Novartis Pharmaceuticals Corporation | 6 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $112 |
| Lilly USA, LLC | 5 | $110 |
| Journey Medical Corporation | 5 | $109 |
| Incyte Corporation | 5 | $103 |
| ABBVIE INC. | 4 | $90 |
| UCB, Inc. | 4 | $77 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
Products named: COSENTYX, ADBRY, EBGLYSS, Opzelura, SKYRIZI, Bimzelx, Winlevi, DUPIXENT.
Industry payments across AL — which companies pay providers there.
